Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
Emily R FinchLaura J JankeColton A SmithSeth E KarolDeqing PeiCheng ChengSue C KasteHiroto InabaChing-Hong PuiJoshua WolfMary V RellingPublished in: Pediatric blood & cancer (2019)
These data identify systemic infection during ALL therapy as a novel risk factor in the development of glucocorticoid-induced osteonecrosis.